26 results
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd
31 May 23
Report of Foreign Private Issuer
8:09am
of the International Society for Cell & Gene Therapy
Nes-Ziona, Israel, May 31, 2023 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company … a selected Elevator Pitch Presentation at the 2023 Annual Meeting of the International Society for Cell & Gene Therapy (ISCT), which is taking place from
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd
1 Mar 21
Report of Foreign Private Issuer
7:58am
of the top 400 over 15,153,100 author identifiers) by the European Society for Clinical Investigation; and one of the top “List of 500 Most Highly Cited … of numerous honors and awards, including “Roll of Honour” of the International Union Against Cancer; Gold Medal of the Swedish Society of Physicians
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd
31 May 22
Report of Foreign Private Issuer
8:04am
Checkpoint Inhibition at the American Society of Clinical Oncology (ASCO) Annual Meeting
Stand-alone therapy with PD1 checkpoint inhibitors has shown … THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY
Founded in 1964, the American Society of Clinical Oncology is the world’s leading professional
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd
6 Jun 22
Report of Foreign Private Issuer
8:03am
with cancer, following encouraging preclinical data presented at the International Society for Gene and Cell Therapy 2022 conference, and preclinical data … in ovarian cancer presented at the American Society of Clinical Oncology 2022 conference
Nes-Ziona, Israel, June 6, 2022 (GLOBE NEWSWIRE) – Enlivex
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd
28 May 20
Report of Foreign Private Issuer
9:25am
at the International Society for Cellular Therapy 2020 Paris Virtual Annual Meeting
- Exploratory endpoint analyses demonstrated Allocetra’s potential … trial of AllocetraTM in patients with sepsis will be presented as part of an oral presentation at the International Society for Cellular Therapy (ISCT
6-K
EX-99.1
yj5ijbgw ehnknecrv
6 Jul 22
Current report (foreign)
8:41am
6-K
EX-99.1
ktsrks5 48s
9 May 22
Report of Foreign Private Issuer
9:10am
6-K
s169782w 0m2aavh
31 May 23
Report of Foreign Private Issuer
8:09am
6-K
d0j22snph nax10odqmn
9 May 22
Report of Foreign Private Issuer
9:10am
6-K
ph0x 3nj0
28 May 20
Report of Foreign Private Issuer
9:25am
6-K
EX-99.3
z0l4j1aeonf51nm
22 Aug 22
Condensed Consolidated Financial Statements
8:08am
6-K
EX-99.1
j6sqpmxa tvgh
2 Feb 15
Bio Blast Announces Key Leadership Changes
12:00am
6-K
EX-99.1
84vrzv988pdw6qv0dk
12 Sep 22
Report of Foreign Private Issuer
8:02am
6-K
EX-99.1
yb8vn56abb jdrk
5 Dec 22
Enlivex Announces Third Quarter 2022 Financial Results and Provides a Business Update
8:05am
6-K
5aam8kv 4z
27 Mar 19
Securities Purchase Agreement
8:32am
F-1/A
a4j0hgbn9b61erxwkad
8 Jul 14
Registration statement (foreign) (amended)
12:00am
424B4
zlbdf06 3chw
31 Jul 14
Prospectus supplement with pricing info
12:00am
20-F
mpb3r 056
31 Mar 15
Annual report (foreign)
12:00am
424B5
0neacdj
30 Dec 22
Prospectus supplement for primary offering
4:01pm